Abstract
curve within the dilution range assayed. Luteinizing hormone (LH) was measured using 23 a micro-modified version of a previously described radioimmunoassay (Sharp et al., 24 1987) . Samples (day 3 only) were run in a single assay, in duplicate when sample 25 volume permitted (>90% of all samples), diluted 1 in 2.3 in radioimmunoassay (RIA) 26 buffer. Assay sensitivity was determined as described above, with a lower limit of 27 0.087ng·mL -1 . Samples that fell below the detection limit of the assays were given the 28 median between the cut-off and the lowest measured value, and analyses using these 29 data yielded qualitatively similar results as when they were excluded. The intra-assay 30 8 coefficient of variation for the LH assay was 6.4% for a high value pool and 8.1% for a 1 low value pool, and a curve generated by serial dilution of zebra finch plasma ran 2 parallel to the standard curve within the dilution range assayed. 3 4
Bromocriptine treatment 5
Manipulating PRL in birds for a sustained length of time through active or passive 6 immunization, or through exogenous PRL administration, has proven challenging, 7 (Sockman et al., 2000; A. Dawson and P. Sharp, unpublished data) . Similarly, injection 8 of vasointestinal peptide (VIP) provides only short-term changes in circulating PRL 9 levels, and only in non-breeding birds (Christensen and Vleck, 2008) . Therefore, we 10 used the dopamine (D 2 and D 3 ) receptor agonist, bromocriptine (2-bromo--ergocriptine 11 mesylate; Enzo, PA, USA) to manipulate plasma PRL levels. Bromocriptine binds to the 12 inhibitory D 2 receptor on secretory lactotroph cells in the pituitary, and has been widely 13 used to lower PRL in mammals, but less commonly in birds (see references below). 14 Females were randomly assigned to either one of two doses of bromocriptine (low, n = 15 13, 333µg/kg body weight or high, n = 14, 3333µg/kg body weight w/v in DMSO 16 (dimethylsulfoxide; Sigma-Aldrich, MO, USA), or vehicle only control (n = 11, 35-45 µL 17 DMSO based on mass, as for bromocriptine). Doses were based on previous work in 18 mammals (Bales et al., 2002; Bridges and Ronsheim, 1990; Roberts et al., 2001) and 19 birds (Angelier et al., 2006; Jouventin and Mauget, 1996) . Bromocriptine was 20 administered by intra-muscular injection into the pectoral muscle, daily between 1100 21 and 1300 hours beginning the day the first egg was laid and terminating at clutch 22 completion (see section 2.1). The timing of the first bromocriptine injection was chosen 23 to limit undue stress from injections and to prevent premature decreases in PRL, both of 24 which could have prevented gonadal development and the initiation of laying (Angelier 25 and Chastel, 2009; Maney et al. 1999; Small et al. 2007 ). On egg day three of the 26 bromocriptine experiment, injections were carried out immediately after blood sampling 27 (see section 2.2). 28 9 1
Data analysis 2
Data were first examined for normality, outliers, collinearity and interactions between 3 explanatory variables. Both hormones showed deviations from normality, which was 4 improved with log transformation. Log transformed data are described using median 5 and interquartile range; otherwise data are stated as mean ± standard error. 6
Repeatability was calculated using previously described methods (Lessells and Boag, 7 1987) . Since there were no statistical differences in the results found using mass alone 8 or the residuals of a regression of mass by tarsus, mass alone was used as the 9 measure of condition in all relevant analyses. For hormone analyses, only clutches 10 equal or greater to the day the blood sample was taken were included ( 3 eggs day 3 11 and experimental breeding, 2 eggs for day 2, 4 eggs for day 4). Several females laid 12 clutches larger than those normally observed in the wild (2-7 eggs; Zann, 1996). Since 13 breeding conditions, analyses were 14 run including and excluding these data. Results from both datasets are presented when 15 the model outcomes differed, otherwise results include larger than normal clutch sizes. 16
For the bromocriptine experiment we predicted individual increases in clutch size in 17 response to the treatment, specifically those greater than the range observed in free-18 living birds. 19
Pre-breeding and simple breeding comparisons (excluding clutch size; see 20 below) were conducted using ANOVA or ordinary least squares regression. To examine 21 females through treatment and time (i.e. between pre-breeding and breeding; between 22 control breeding and bromocriptine breeding), we used linear mixed effects models for 23 repeated measures with individual female as a random factor, carried out in the 24 (Pinheiro et al., 2011; R Core Development Team, 25 2011) . This experimental and statistical design allowed us to make intra-individual 26 comparisons of the effects of treatment, so that treated females were compared to 27 themselves under the untreated breeding conditions (in addition to retaining a vehicle 28 only control group for bromocriptine, see section 2.3). For each stage, a small subset of 29 females did not provide sufficient plasma for both hormone assays, failed to breed, or 30 laid less than 3 eggs (i.e. no hormone values for egg day three). As a result, model 1 degrees of freedom vary, based on the maximum number of available data points. 2
Since clutch size is a discrete count variable, all analyses of this trait were 3 conducted using generalized linear or generalized linear mixed effects models, with 4 quasipoisson family to account for underdispersion 5 Weisberg, 2011). Analyses of egg mass was conducted on mean egg mass within a 6 clutch, and yielded similar results to models incorporating all eggs, laying order and 7 individual female as a random factor. All analyses were followed with standard model 8 validation procedures to test the assumptions of the test employed. Data points with 9 > 4/n) were considered influential, and outputs are 10 presented for models including and excluding these points for transparency. Where 11 multiple explanatory variables were found to affect a dependent variable, p-values are 12
given for the full model including all significant variables (ANCOVA). 13 Compared to pre-breeding levels, LH was significantly higher during the 3-egg 27 stage in breeding females (estimate for effect of breeding stage on LH S.E.: 0.098 28 0.051 ng/mL, df = 31, t = 2.38, P = 0.024; Intercept: 0.265 0.039, df = 40, t = -9.77, P 29 < 0.001; Table 1 ). Furthermore, individual variation in LH was repeatable between pre-30 breeding and breeding stages (R = 0.51; 95% CI = 0.25, 0.77; P < 0.002). Pre-breeding 1 LH was negatively correlated with laying interval after controlling for the time elapsed 2 between pre-breeding blood sampling and subsequent pairing -females with higher pre-3 breeding LH had shorter intervals between pairing and laying of the first egg (F 2,31 = 4 15.52, P < 0.001; Fig. 2 ). However, pre-breeding LH was not significantly correlated with 5 either mean egg mass (F 2,30 = 1.66, P = 0.207) or clutch size (Likelihood-ratio test: 2 = 6 0.011, df = 1, P = 0.915) of the subsequent breeding attempt. 7
Breeding PRL levels at the 3-egg stage were markedly and significantly higher 8 than pre-breeding levels (Estimate for effect of breeding stage on PRL S.E.: 180 9 24ng/mL, df = 38, t = 19.17, P < 0.001; Intercept: 23.07 2.03, df = 41, t = 37.21, P < 10 0.001; Table 1 ). However, in contrast to LH, individual PRL levels were not repeatable 11 between pre-breeding and breeding stages (P > 0.90). Log laying interval, egg mass, 12
and clutch size were all independent of pre-breeding PRL levels (P > 0.10 in all cases). 13 14
Relationships between breeding LH, PRL and reproductive traits 15
Mean egg mass was significantly and positively correlated with body mass at 16 pairing (F 1,39 = 5.72, P = 0.022), but not laying interval (F 1,39 = 1.29, P = 0.264). In 17 contrast, clutch size was independent of mass at pairing (Likelihood-ratio test: 2 = 18 0.873, df = 1, P = 0.350), but negatively correlated with laying interval (Likelihood-ratio 19 test: 2 = 9.234, df = 1, P = 0.002). Neither egg mass or clutch size was significantly 20 correlated with individual variation in breeding plasma LH (P > 0.15 for both). Breeding 21 plasma PRL on egg day 3 was significantly correlated with variation in mean egg mass 22 (F 1,37 = 5.38, P = 0.026) and clutch size ( 2 = 9.17, df = 1, P = 0.002; Fig. 3A ), but these 23 effects were inconsistent and skewed by several influential data points (i.e. high 24 leverage points from clutch sizes outside the range normally observed in the wild [>7 25 eggs; Zann 1996]). Within the normal range of clutch sizes, both mean egg mass and 26 clutch size were independent of variation in breeding PRL at day 3 of egg-laying (F 1,34 = 27 0.004, P = 0.950 and 2 = 0.227, df = 1, P = 0.634, respectively; Fig. 3A ). Similarly, in 28 the follow-up study, variation in clutch size was independent of variation in breeding 29 PRL on day 2 ( 2 = 0.115, df = 1, P = 0.735) and day 4 ( 2 = 2.69, df = 1, P = 0.101) of 1 egg-laying. 2 3
LH, PRL, and reproductive traits for bromocriptine treatment breeding 4
Luteinizing hormone levels decreased significantly between the control and 5 bromocriptine breeding attempts (estimate for effect of breeding attempt on LH S.E.: -6 0.133 0.029 ng/mL, df = 31, t = -3.20, P = 0.003; Intercept: 0.32 0.045, df = 34, t = 7 7.46, P < 0.001; Table 1 ), but this effect was not different for the control group or either 8 treatment (Breeding attempt *Treatment; Likelihood-ratio test: 2 = 1.56, df = 2, P = 9 0.460). Similarly, hematocrit dropped significantly for the bromocriptine breeding 10 attempt (estimate for effect of Breeding attempt on hematocrit S.E.: -0.03 0.01, df = 11 31, t = -5.30, P < 0.001; Intercept: 0.481 0.001, df = 34, t = 75.86, P < 0.001; Table 1) , 12 a change that also did not differ between control or treatment groups (Breeding attempt 13 *Treatment; Likelihood-ratio test: 2 = 0.51, df = 2, P = 0.776). 14 Prolactin levels were not significantly different between the control and 15 bromocriptine breeding attempts (estimate for effect of breeding attempt on PRL S.E.: 16 -1.64 3.65 ng/mL, df = 31, t = -0.22, P = 0.824; Intercept: 197.26 7.31, df = 34, t = 17 139.82, P < 0.001; Table 1 ). There were no differences in PRL by treatment group 18 (Treatment; Likelihood-ratio test: 2 = 2.93, df = 2, P = 0.230), nor any interaction 19 between breeding attempt and treatment (Breeding attempt *Treatment; Likelihood-ratio 20 test: 2 = 1.12, df = 2, P = 0.571). In fact, individual PRL levels between the control and 21 bromocriptine treatment breeding attempts were repeatable (R = 0.54; 95% CI = 0.28-22 0.79; P < 0.001). Since there was no effect of treatment on PRL or clutch size between the control 6 and bromocriptine breeding attempts, we pooled treatment groups from the 7 experimental breeding for further analyses. As in the control breeding attempt, clutch 8 size was independent of plasma PRL for the experimental breeding 
Discussion 22
In this study we investigated individual variation in pre-breeding and breeding hormone 23 (PRL and LH) levels in relation to variation in reproductive traits (timing of laying, egg 24 mass, clutch size), specifically to test the hypothesis that variation in circulating PRL 25 levels mediates clutch size variation via the inhibition of LH (Haywood, 1993; Lea et al., 26 1981; Meijer et al., 1990; Sockman et al., 2006) . Clutch size was independent of 27 variation in pre-breeding PRL or LH, although pre-breeding LH was negatively 28 correlated with the time between pairing and the onset of egg-laying. We also found no 29 evidence for any inverse relationships between plasma PRL and plasma LH levels 30 14 which would have been consistent with an inhibitory effect of PRL on LH. In contrast to 1 previous studies (Badyaev and Duckworth, 2005; Reddy et al., 2007) we observed no 2 effect of bromocriptine on circulating PRL. Nonetheless, and most importantly, we found 3 no evidence to support a causal relationship between individual variation in breeding 4 plasma PRL levels and variation in clutch size in multiple different breeding attempts 5 and for PRL measured on either days 2, 3 or 4 of egg-laying, i.e. during the temporal 6 window when follicular inhibition and clutch size determination is thought to occur. The 7 only evidence we found to support a link between PRL and clutch size was a negative 8 relationship between individual change in PRL between the control and experimental 9 breeding and individual change in clutch size. While we think this result is interesting we 10 acknowledge this may not be reflective of a causal relationship. Thus our data, from 11 multiple different breeding attempts, fail to provide any support for the involvement of 12 circulating PRL early in egg-laying on clutch size determination. 13
We first examined variation in pre-breeding PRL and LH and condition-related 14 traits (e.g. body mass, hematocrit) to test the hypothesis that individual variability in 15 these characteristics could be predictive of subsequent reproductive performance 16 (Chastel et al., 2003; Crossin et al., 2012; Ouyang et al., 2011) . We observed no 17 relationship between pre-breeding hematocrit or body mass and pre-breeding PRL or 18 LH. We also found no effect of pre-breeding mass, hematocrit, PRL or LH on 19 subsequent clutch size. These results do not support the hypothesis that plasma PRL or 20 LH prior to breeding provide an ea 21 performance, at least for In 22 addition, plasma PRL and LH were significantly, positively correlated in pre-breeding 23 female zebra finches which contrasts with results from other studies, mostly in breeding 24 poultry, which have demonstrated an inhibitory effect of PRL on LH hormone titres or 25 LH mRNA expression (Rozenboim et al., 1993; You et al., 1995) . Although the 26 correlation between these two traits in our study was not particularly strong, our results 27 are consistent with growing evidence that PRL can have both inhibitory and stimulatory 28 effects on gonadal function, depending on reproductive state and PRL concentration 29 (Hrabia et al., 2004; Li et al., 2011; Maney et al., 1999; Small et al., 2007) . The origin of 30 the positive correlation between PRL and LH is not obvious; LH activates the 1 reproductive axis and steroidogenesis, and steroid hormones can stimulate PRL 2 secretion (El Halawani et al., 1983; Mauro et al., 1992) . However, since non-3 photoperiodic cues (e.g. social stimuli) likely contribute to variation in pre-breeding LH 4 levels in opportunistically breeding species like the zebra finch (e.g. Maney et al., 1999; 5 Perfito et al., 2007; Small et al., 2007) , pre-breeding LH and PRL may reflect individual 6 differences in the relative activation of the reproductive axis prior to actual onset of egg-7 8 Individual differences in reproductive readiness are supported in our study by the 9 positive correlation between pre-breeding LH levels and the interval between pairing 10 and laying -females with relatively high pre-breeding LH were the quickest to initiate 11 laying. Presumably, variability in pre-breeding LH is indicative of the differences in the 12 developmental state of the ovary and nascent follicles, a suggestion supported by other 13 work in captive pre-breeding zebra finches (see Fig. 4 (Lea et al., 1981; Sockman et al., 2006) . This component of the model 28 predicts an inverse relationship between these hormones, at least at the time of clutch 29 size determination. We were able to examine the relationship between these two 30 hormones, and how they changed over time, by tracking individual hormonal profiles 1 through the transition between pre-breeding and breeding states. Breeding LH levels 2 were moderately though significantly higher than pre-breeding levels, and were 3 repeatable between pre-breeding and breeding states. In contrast, plasma PRL levels 4 increased dramatically (as high as 27 fold) between pre-breeding and egg day 3, and 5 PRL levels on egg day 3 were independent of pre-breeding PRL. Although LH levels on 6 day three were probably beginning to decline (based on rapid decreases in estradiol 7 around this time; Williams et al., 2005) , our data still suggest an uncoupling of the 8 positive correlation between PRL and LH that we observed in pre-breeding females. An 9 uncoupling of these two hormones over time does not support the idea of a systemic 10 inhibitory effect of PRL on LH, since in our study both hormones increase with breeding, 11 yet vary independently between pre-breeding and breeding states. Accordingly, we also 12 found no significant relationship between breeding levels of PRL and LH. Furthermore, 13 while experimental bromocriptine treatment had no effect on circulating PRL (discussed 14 below), we again found no evidence for an inhibitory effect of PRL on LH in our 15 experimental breeding. Though correlational, the lack of empirical support for an 16 inhibitory effect of PRL on LH in this study, as well as in other passerines (Buntin et al., 17 1999; Meier and Dusseau, 1968; Small et al., 2007) , raises questions about the 18 universality of the PRL-dependent control of LH in the current mechanistic hypothesis, 19 and its applicability in this taxon. 20
In contrast to previous studies on mammals (Bridges and Ronsheim, 1990; 21 Palestine et al., 1987) and some avian species (Angelier et al., 2006; Jouventin and 22 Mauget, 1996; Reddy et al., 2007) we found that bromocriptine treatment had no effect 23 on circulating PRL levels in zebra finches for either the low or high dose groups, nor did 24 we observe a treatment effect on clutch size between the control and experimental 25 breeding. While a range of bromocriptine doses have been employed in birds, from as 26 low as 14 g·kg -1·day-1). In addition, several studies using injections 2 of bromocriptine reported significant decreases in PRL within 3 days (Roberts et al. 3 (2001; Angelier et al. 2006 ) approximately the targeted time-frame in our study. Thus, 4 the reason for the failure of bromocriptine to effect PRL levels in our study is not clear, 5 though this is not restricted to T. guttata (e.g. bromocriptine had no effect on PRL in 6 Rissa tridactyla; F. Angelier, pers. comm.). In contrast, the decrease in both LH and 7 hematocrit we did observe is best explained by injection treatments that all birds, 8 including controls, received, since this effect did not differ by treatment group. 9
The PRL-based mechanism for clutch size determination predicts a clear 10 negative relationship between plasma PRL and clutch size, i.e. females with higher 11
circulating PRL early during laying should lay smaller clutches, due to the earlier and/or 12 greater inhibitory effect of elevated plasma PRL (Sockman et al., 2000) . We found that 13 variation in PRL levels during what is believed to be the critical period for clutch size 14 determination in the zebra finch (day 3 of egg-laying) were not associated with 15 differences in clutch size (cf Sockman et al., 2000) . Furthermore, in our follow-up study 16 variation in plasma PRL on day 2 and day 4 of egg-laying, bracketing the putative time 17 window for clutch size determination, was also unrelated to clutch size. Thus, although 18 the current model for clutch size determination has focused on an inhibitory role for 19 circulating plasma PRL early in laying (Haywood, 1993; Sockman et al., 2000) , our 20 results suggest that individual variation in absolute plasma PRL is not involved in clutch 21 size determination. Furthermore, we found no evidence for an inhibitory effect of PRL 22 on LH. Given our sample sizes and the range of clutch sizes, as well as the tightly 23 controlled diet, photoperiod, age and reproductive history of the individuals included in 24 the study, we believe our study provides a robust test of the PRL-based model for clutch 25 size determination, which posits a regulatory role for circulating PRL during early egg-26 laying (Meijer et al., 1990) . Nevertheless, alternative mechanisms, still involving PRL, 27 are worth considering, e.g. differential PRL receptor expression, polymorphisms in gene 28 and receptor, or tissue specific-receptor expression among individuals, could all affect 29 the biological activity and effects of a given plasma concentration of PRL (Zadworny et 1 al., 2002) . 2 While any PRL-based mechanism for clutch size determination does not appear 3 to involve an absolute inhibitory threshold at the scale of the population, individual 4 differences in either the rate of increase or in the inhibitory threshold (relative PRL level 5 for inhibition for a given breeding attempt) remain plausible alternatives to, or 6 modifications of, the mechanistic model in its current form (Meijer et al., 1990; Williams, 7 2012b, p. 186) . The only evidence we found to support a link between PRL and clutch 8 size was a negative relationship between individual changes in PRL between the control 9 and experimental breeding and individual changes in clutch size. If this finding is robust, 10 the fact that changes in PRL between breeding attempts were not associated with 11 changes in LH, nor were changes in LH associated changes in clutch size, may imply 12 downstream regulatory effects of PRL (e.g. at the level of the ovary). Although 13 speculative, this hypothesis is supported by work demonstrating the presence of PRL 14 receptors in ovarian follicles (Ohkubo et al., 1998) , which can directly inhibit the effects 15 of follicle-stimulating hormone (FSH) and LH on, as well as estrogen and progesterone 16 secretion from, the avian ovary (Hrabia et al., 2004; Li and Yang, 1995) . 17
Studying avian clutch size determination by looking at individual co-variation in 18 PRL and egg number may suggest more biologically-relevant alternatives to the 19 mechanistic hypothesis in its current form (Haftorn, 1981; Haywood, 1993; Meijer et al., 20 1990 ), a hypothesis we found no support for in this study. Further experimental work 21 successfully uncoupling PRL from clutch size is necessary to reinforce this conclusion. 22
If the hormonal regulatory control of clutch size is superimposed upon individual 23 variation in downstream effectors (e.g. receptor expression in the ovary), repeated 24 measurements of individuals through time, as conducted in this study, have the benefit 25 of eliminating at least a portion of these potentially confounding effects, which might 26 bring questions about the endocrine control of this key life history trait into greater focus. 27
At present though, it seems most parsimonious to assume that the putative relationship 28 between circulating PRL early in egg-laying and clutch size simply reflects a temporal 29 coincidence, and that the increase in PRL at this time is functionally associated with 30 onset or maintenance of incubation -a link that is better supported by experimental data 1 (Lea and Sharp, 1989 
